| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.027 | 0.6 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.029 | 0.6 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.033 | 0.6 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.6 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |